MARKET

SSKN

SSKN

STRATA Skin
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.130
-0.052
-4.39%
After Hours 19:13 07/10 EDT
OPEN
1.170
PREV CLOSE
1.182
HIGH
1.180
LOW
1.090
VOLUME
120.17K
TURNOVER
--
52 WEEK HIGH
2.920
52 WEEK LOW
0.7520
MARKET CAP
38.10M
P/E (TTM)
-10.5116
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SSKN stock price target is 4.875 with a high estimate of 6.00 and a low estimate of 3.750.

EPS

SSKN News

More
Edited Transcript of SSKN.OQ earnings conference call or presentation 12-May-20 12:30pm GMT
Thomson Reuters StreetEvents · 07/03 00:29
How Hedge Funds Traded Strata Skin Sciences, Inc. (SSKN) During The Crash
Insider Monkey · 05/28 20:25
US$4.88: That's What Analysts Think STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Is Worth After Its Latest Results
Simply Wall St. · 05/14 16:34
STRATA Skin Sciences's (SSKN) CEO Dr. Dolev Rafaeli on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/12 19:06
Strata Skin Sciences Q1 EPS $(0.030) Beats $(0.050) Estimate, Sales $6.700M Beat $5.870M Estimate
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.030) per share which beat the analyst consensus estimate of $(0.050) by 40 percent. This is a 25 percent increase over losses of $(0.040) per share from
Benzinga · 05/12 12:01
STRATA Skin Sciences Reports First Quarter 2020 Financial Results
Recurring revenue for the first quarter of 2020 grew 7.3% over first quarter 2019Total gross margins in the first quarter of 2020 grew 3.8% over first quarter 2019 Global.
GlobeNewswire · 05/12 12:00
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week.
Benzinga · 05/10 19:40
STRATA Skin Sciences to Host First Quarter 2020 Financial Results and Business Update Conference Call on May 12
GlobeNewswire · 05/05 13:00

Industry

Advanced Medical Equipment & Technology
-0.60%
Healthcare Equipment & Supplies
-0.31%

Hot Stocks

Symbol
Price
%Change

About SSKN

STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company's technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.
More

Webull offers kinds of STRATA Skin Sciences Inc stock information, including NASDAQ:SSKN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SSKN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SSKN stock methods without spending real money on the virtual paper trading platform.